e. Assuming the accuracy of the representations and warranties of the Investor set forth herein, the Issuer is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority, self-regulatory organization or other person in connection with the issuance of the Securities pursuant to this Agreement, other than (i) filings with the SEC, (ii) filings required by applicable state securities laws, and (iii) consents, waivers, authorizations, orders, notices or filings, the failure of which to obtain or make, would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
f. The Issuer is not, and immediately after receipt of payment for the Securities, will not be, an “investment company” within the meaning of the Investment Company Act of 1940, as amended.
g. The Issuer is in compliance with all applicable laws, except where such non-compliance would not reasonably be expected to have a Material Adverse Effect. The Issuer has not received any written communication from a governmental authority that alleges that the Issuer is not in compliance with or is in default or violation of any applicable law, except where such non-compliance, default or violation would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.
h. Assuming the accuracy of the Investor’s representations and warranties set forth in Section 6 of this Agreement, no registration under the Securities Act is required for the offer and sale of the Securities by the Issuer to the Investor.
i. Neither the Issuer nor any person acting on its behalf has offered or sold the Securities by any form of general solicitation or general advertising and the Securities are not being offered in a manner involving a public offering under, or in a distribution in violation of, the Securities Act or any state securities laws.
j. The Issuer is not under any obligation to pay any broker’s fee or commission in connection with the sale of the Securities to the Investor.
k. As of the date hereof, the total authorized capital stock of the Issuer is (i) 4,600,000,000 shares of Common Stock, of which 244,220,336 are issued and outstanding as of the date of this Agreement and as of the Closing and prior to the Closing, and (ii) 3,340,121,789 shares of Preferred Stock, $0.0001 par value per share (the “Preferred Stock”), of which 2,180,734,856 are issued and outstanding as of the date of this Agreement and as of the Closing and prior to the Closing. All issued and outstanding shares of Common Stock and shares of Preferred Stock have been duly authorized and validly issued, are fully paid and are non-assessable and are not subject to preemptive rights. Except as set forth in the Issuer’s organizational documents, there are no outstanding contractual obligations of the Issuer to repurchase, redeem or otherwise acquire any shares of Common Stock or Preferred Stock or any other capital stock of the Issuer. The Issuer has reserved 155,862,631 shares of Common Stock for issuance to officers, directors, employees and consultants of the Issuer pursuant to its 2015 Equity Incentive Plan duly adopted by the Board of Directors and approved by the Issuer stockholders (the “Stock Plan”). Of such reserved shares of Common Stock, no shares have been issued pursuant to restricted stock purchase agreements, options to purchase 152,138,783 shares of Common Stock have been granted and are currently outstanding, and 3,723,848 shares of Common Stock remain available for issuance to officers, directors, employees and consultants pursuant to the Stock Plan. The Issuer has reserved 46,392,432 shares of Common Stock for issuance upon exercise of warrants and 535,749,799 shares of Common Stock for issuance in connection
5